1. Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status. Issue 9 (29th January 2013) Authors: Ribera, Josep‐Maria; García, Olga; Grande, Carlos; Esteve, Jordi; Oriol, Albert; Bergua, Juan; González‐Campos, José; Vall‐llovera, Ferran; Tormo, Mar; Hernández‐Rivas, Jesús‐Maria; García, Daniel; Brunet, Salut; Alonso, Natalia; Barba, Pere; Miralles, Pilar; Llorente, Andreu; Montesinos, Pau; Mo... Journal: Cancer Issue: Volume 119:Issue 9(2013) Page Start: 1660 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab). Issue 9 (29th January 2013) Authors: Ribera, Josep‐Maria; García, Olga; Grande, Carlos; Esteve, Jordi; Oriol, Albert; Bergua, Juan; González‐Campos, José; Vall‐llovera, Ferran; Tormo, Mar; Hernández‐Rivas, Jesús‐Maria; García, Daniel; Brunet, Salut; Alonso, Natalia; Barba, Pere; Miralles, Pilar; Llorente, Andreu; Montesinos, Pau; Mo... Journal: Cancer Issue: Volume 119:Issue 9(2013) Page Start: 1660 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗